Methyluracil (Methyluracil)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
    TULA PHARMACEUTICAL FACTORY, LTD.     Russia
  • Methyluracil
    ointment locally externally 
    St. Petersburg Research Institute of Vaccines and Serums and the enterprise for the production of bacterial preparations FSUE FMBA    
  • Methyluracil
    suppositories rect. 
    Promomed Rus, Open Company     Russia
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
    MUROMSKY INSTRUMENT-MAKING PLANT, OJSC     Russia
  • Methyluracil
    ointment locally externally 
    Promomed Rus, Open Company     Russia
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
    BELKOZIN - LUZHSKY FACTORY, OJSC     Russia
  • Oxolin
    ointment externally 
    TULA PHARMACEUTICAL FACTORY, LTD.     Russia
  • Stisamet®
    ointment locally externally 
    RETYNOIDS FNPP, CJSC     Russia
    • Dosage form: & nbspointment for topical and topical application
    Composition:Active substance: dioxomethyltetrahydropyrimidine (methyluracil) -10 g,

    Excipients: Vaseline medical - 45 g, lanolin anhydrous - 31.5 g, purified water - 13.5 g.

    Description:Homogeneous ointment light yellow or light beige.
    Pharmacotherapeutic group:Stimulator tissue regeneration
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Has anabolic activity. Normalizing the nucleic acid metabolism, accelerates the processes of cellular regeneration in wounds, accelerating the growth and granulation maturation of tissue and epithelization.

    When applied locally on the wound, it has photoprotective properties.

    Indications:

    Sluggish wounds, burns, photodermatitis.

    Prevention of skin reactions when irradiating neoplasms with low radiosensitivity, reducing symptoms of radiation dermatitis and late fusion of the walls (occlusion) of the vagina - in the case of radiotherapy of neoplasms of the genitals.

    Contraindications:Hypersensitivity to the drug. Redundancy of granulations.
    Dosing and Administration:

    Locally and externally: ointment is applied daily to the damaged areas for 5-10 g for 15-30 days. Ointment is used in loose tampons with late radiation damage to the vagina.

    Side effects:Allergic reactions, short-term burning.
    Interaction:

    Methyluracil ointment is compatible with external applications of sulfonamides, antibiotics and antiseptics.

    Form release / dosage:Ointment for topical and topical application 10%.
    Packaging:

    25 grams per aluminum tube. Each tube, together with instructions for use, is placed in a cardboard pack.

    Storage conditions:At a temperature of 12 to 15 ° C. Keep away from children.
    Shelf life:

    3 years 6 months

    Do not use after the expiration date stated on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-001520
    Date of registration:16.02.2012
    Expiration Date:Unlimited
    The owner of the registration certificate:St. Petersburg Research Institute of Vaccines and Serums and the enterprise for the production of bacterial preparations FSUE FMBASt. Petersburg Research Institute of Vaccines and Serums and the enterprise for the production of bacterial preparations FSUE FMBA
    Manufacturer: & nbsp
    Information update date: & nbsp08.05.2018
    Illustrated instructions
      Instructions
      Up